Founded in 2015 and based in Leuven, Belgium, Fund+ invests in seed-stage, early-stage, and later-stage life science companies in Belgium, with a focus on diagnostics, therapeutics, and medical devices. The firm aims to contribute to the development of a leadership position in the life sciences sector while generating a tangible, beneficial societal impact. Fund+ is an open-ended fund for long-term equity investment in innovative life sciences companies.